TrademarkDir
LIQUIXR
LIVE

Serial Number

77517107

Owner

TRIS PHARMA, INC.

Attorney

Cathy A Kodroff

First Use Date

Dec 31, 2010

Filing Date

Jul 8, 2008

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LIQUIXR Trademark

Serial Number: 77517107 • Registration: 3944722

LIQUIXR is a trademark filed by TRIS PHARMA, INC. on July 8, 2008. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TRIS PHARMA, INC. (33 trademarks)

2033 ROUTE 130
MONMOUTH JUNCTION, NJ 08852

Entity Type: 03

Trademark Details

Filing Date

July 8, 2008

Registration Date

April 12, 2011

First Use Anywhere

December 31, 2010

First Use in Commerce

December 31, 2010

Published for Opposition

November 24, 2009

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 25, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 25, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 25, 2021 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jul 29, 2021 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jul 21, 2021 PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jul 21, 2021 PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Jul 21, 2021 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 21, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 12, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 12, 2020 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 31, 2018 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 3, 2018 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 20, 2017 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 30, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 30, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 30, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 16, 2016 E815
REGISTERED-PRINCIPAL REGISTER
Apr 12, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 10, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Mar 9, 2011 REGV
ASSIGNED TO LIE
Mar 8, 2011 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 1, 2011 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2011 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Feb 28, 2011 SUPC
SOU EXTENSION 2 GRANTED
Feb 28, 2011 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 25, 2011 AITU
USE AMENDMENT FILED
Feb 10, 2011 IUAF
SOU EXTENSION 2 FILED
Feb 10, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 10, 2011 EEXT
TEAS STATEMENT OF USE RECEIVED
Feb 10, 2011 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 7, 2010 EXRA
SOU EXTENSION 1 GRANTED
Aug 5, 2010 EX1G
SOU EXTENSION 1 FILED
Aug 5, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 5, 2010 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 16, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 24, 2009 NPUB
PUBLISHED FOR OPPOSITION
Nov 24, 2009 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 22, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 20, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 20, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 20, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 20, 2009 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 30, 2009 GNFN
FINAL REFUSAL E-MAILED
Apr 30, 2009 GNFR
FINAL REFUSAL WRITTEN
Apr 30, 2009 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2009 CRFA
ASSIGNED TO LIE
Apr 8, 2009 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2009 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 16, 2008 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 16, 2008 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Oct 16, 2008 CPEA
ASSIGNED TO EXAMINER
Oct 14, 2008 DOCK
NEW APPLICATION ENTERED
Jul 11, 2008 NWAP

Related Trademarks

More from this Owner

ONYDA XR logo

ONYDA XR

ADNEURIS

ADNEURIS

ADNEURIS

ADNEURIS

ADNEURIS THERAPEUTICS

ADNEURIS THERAPEUTICS

ADNEURIS THERAPEUTICS

ADNEURIS THERAPEUTICS

ONYDA XR logo

ONYDA XR